| Opportunity ID: | 334842 | | Opportunity Number: | RFA-CK-22-006 | | Opportunity Title: | Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases | | Opportunity Category: | Discretionary | | Opportunity Category Explanation: | | | Funding Instrument Type: | Cooperative Agreement | | Category of Funding Activity: | Health | | Category Explanation: | | | CFDA Number(s): | 93.084 | | Eligible Applicants: | State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) | | Additional Information on Eligibility: | The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits (Other than Institutions of Higher Education) Eligible Agencies of the Federal Government Faith-based or Community-based Organizations U.S. Territory or Possession Regional Organizations Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via https://www.grants.gov Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency’s existing in-house or contractor resources. FFRDC’s enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://gov.ecfr.io/cgi-bin/searchECFR Foreign Organizations: a Foreign Organization is a public or private organization, whether non-profit or for-profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of the project staff or place of performance. Foreign components of U.S. Organizations. For this announcement, applicants may include collaborators or consultants from foreign institutions. | | Agency Code: | HHS-CDC-HHSCDCERA | | Agency Name: | Department of Health and Human Services
Centers for Disease Control and Prevention – ERA | | Posted Date: | Jul 22, 2021 | | Last Updated Date: | Jul 22, 2021 | | Estimated Synopsis Post Date: | Jan 04, 2022 | | Fiscal Year: | 2022 | | Award Ceiling: | $250,000 | | Award Floor: | $200,000 | | Estimated Total Program Funding: | $5,000,000 | | Expected Number of Awards: | 4 | | Description: | The purpose of this notice of funding opportunity is to support clinical and applied research that will ultimately help reduce illness and death due to fungal diseases around the world caused by both known and emerging pathogens. | | Version: | 1 |
|
